)% (7) (7) (10) (31)% Gain on Bargain Purchases, impairments and feasibility study(Net)1 12 58 (80)% (14) 1 30 (147)% Other Extraordinary Income/(Expense) (9) (2) 326% (13) (0) (2) 457% = Net Profit after
/Extraordinary income/(expense) (7) (6) (8) (12%) 30 170 (83%) Acquisition cost and pre-operative expense, (7) (5) (8) (11%) (29) (32) (11%) Gain on Bargain Purchases, impairments and feasibility study(Net)1 1 (0
Operational/Extraordinary income/(expense) (0) 52 (6) - 99% Acquisition cost and pre-operative expense (8) (3) (5) (151)% (74)% Gain on Bargain Purchases and impairments (Net)1 (1) 62 (0) - (1566)% Other
, before extraordinary items (34) (13) 93 (163)% (136)% Add: Non Operational/Extraordinary income/(expense) 52 (34) 24 252% 114% Acquisition cost and pre-operative expense (3) (7) (7) 53% 56% Gain on Bargain
(57,544) 9.18% (36,212) 7.63% (21,332) 58.91% Selling expenses (25,720) 4.10% (15,590) 3.28% (10,130) 64.98% Administrative expenses (125,927) 20.09% (123,103) 25.92% (2,824) 2.29% Gain from bargain
expenses (32,336) 2.84% (30,791) 4.05% (1,545) 5.02% Administrative expenses (356,481) 31.28% (316,722) 41.65% (39,759) 12.55% Other expenses - 0.00% (12,702) 1.67% 12,702 100.00% Gain from bargain purchase
% (8,544) 1.01% 8,544 100.00% Bargain purchase of investment in a subsidiary 10,092 1.01% 2,342 0.28% 7,750 330.91% Gain on sale of investment in subsidiary - 0.00% 137,396 16.21% (137,396) 100.00% Reversal
has gains on bargain purchases in Marvel Pack 0.9 mil. As a result, the Company’s equity interest in Marvel Pack 100%. Mil THB Profit sharingTKS Gains on purchases 100% in Marvel Pack TBSP Marvel Pack
Company had a gain from a bargain purchase on investments in subsidiary of THB 0.48 million and received a gain on disposals investment in associated company of THB 0.50 million. Services expenses In 2022
. ASB Cambodia would like AEON Systems to modify the current FEP system to support payWave for both Issuing and Acquiring transaction for VISA. Therefore, ASB Cambodia is required to pay the development